TRAIL: a multifunctional cytokine

被引：109

作者：

Schaefer, Uta ^{[1
]}

Voloshanenko, Oksana ^{[1
]}

Willen, Daniela ^{[1
]}

Walczak, Henning ^{[1
]}

机构：

[1] DKFZ, Tumor Immunol Program, Div Apoptosis Regulat D040, D-69120 Heidelberg, Germany

来源：

FRONTIERS IN BIOSCIENCE | 2007年 / 12卷

关键词：

apoptosis; TRAIL; death receptor; NK cells; tumorigenesis; autoimmunity; clinical development; Review;

D O I：

10.2741/2354

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The Tumor necrosis factor (TNF)-Related Apoptosis Inducing Ligand, TRAIL, has gained much attention due to its specific anti-tumor potential without toxic side effects. TRAIL binds to a complex receptor system. In humans there are two death-inducing receptors for TRAIL while only one is present in mice. The signaling induced by these receptors leads to apoptosis but might also result in activation of survival signals. To assess the safety and possible side effects of TRAIL-based cancer therapy it is necessary to understand the physiological role of the TRAIL/TRAIL-R system. This has been addressed in mice deficient either for TRAIL or for its only murine apoptosis- inducing receptor, TRAIL-R (MK/ mDR5). In this review we will discuss their phenotypes and the results of recent studies on the role of TRAIL in the homeostasis of the immune system, the influence of the TRAIL/TRAIL-R system on infection and autoimmune diseases and the still controversial role of TRAIL in tumorigenesis. Clinical trials with TRAIL and other TRAIL receptor agonists are now under way. It will be exciting to determine which TRAIL-R agonists, either alone or in combination with other anti-cancer therapeutics, will result in better outcome of cancer treatment in the future.

引用

页码：3813 / 3824

页数：12

共 89 条

[1] Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL [J].

Aktas, O ;

Smorodchenko, A ;

Brocke, S ;

Infante-Duarte, C ;

Topphoff, US ;

Vogt, J ;

Prozorovski, T ;

Meier, S ;

Osmanova, V ;

Pohl, E ;

Bechmann, I ;

Nitsch, R ;

Zipp, F .

NEURON, 2005, 46 (03) :421-432

[2] A new TRAIL to therapy of hepatocellular carcinoma: Blocking the proteasome [J].

Anan, A ;

Gores, GJ .

HEPATOLOGY, 2005, 42 (03) :527-529

[3] Upregulation of TRAIL expression on human T lymphocytes by interferon β and glatiramer acetate [J].

Arbour, N ;

Rastikerdar, E ;

McCrea, E ;

Lapierre, Y ;

Dörr, J ;

Bar-Or, A ;

Antel, JP .

MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (06) :652-657

[4] Safety and antitumor activity of recombinant soluble Apo2 ligand [J].

Ashkenazi, A ;

Pai, RC ;

Fong, S ;

Leung, S ;

Lawrence, DA ;

Masters, SA ;

Blackie, C ;

Chang, L ;

McMurtrey, AE ;

Hebert, A ;

DeForge, L ;

Koumenis, IL ;

Lewis, D ;

Harris, L ;

Bussiere, J ;

Koeppen, H ;

Shahrokh, Z ;

Schwall, RH .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162

[5] TRAIL deficiency delays, but does not prevent, erosion in the quality of "helpless" memory CD8 T cells [J].

Badovinac, Vladimir P. ;

Messingham, Kelly A. Nordyke ;

Griffith, Thomas S. ;

Harty, John T. .

JOURNAL OF IMMUNOLOGY, 2006, 177 (02) :999-1006

[6]

Bonavida B, 1999, INT J ONCOL, V15, P793

[7] Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity [J].

Chan, CW ;

Crafton, E ;

Fan, HN ;

Flook, J ;

Yoshimura, K ;

Skarica, M ;

Brockstedt, D ;

Dubensky, TW ;

Stins, MF ;

Lanier, LL ;

Pardoll, DM ;

Housseau, F .

NATURE MEDICINE, 2006, 12 (02) :207-213

[8] Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis [J].

Clancy, L ;

Mruk, K ;

Archer, K ;

Woelfel, M ;

Mongkolsapaya, J ;

Screaton, G ;

Lenardo, MJ ;

Chan, FKM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (50) :18099-18104

[9] tRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality [J].

Corazza, Nadia ;

Jakob, Sabine ;

Schaer, Corinne ;

Frese, Steffen ;

Keogh, Adrian ;

Stroka, Deborah ;

Kassahn, Daniela ;

Torgler, Ralph ;

Mueller, Christoph ;

Schneider, Pascal ;

Brunner, Thomas .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (09) :2493-2499

[10] The role of the Bcl-2 protein family in cancer [J].

Coultas, L ;

Strasser, A .

SEMINARS IN CANCER BIOLOGY, 2003, 13 (02) :115-123

← 1 2 3 4 5 6 7 8 9 →